Ureteral stent symptoms: A systematic review and meta-analysis comparing the use of mirabegron and tamsulosin.

ABSTRACT:

Background

Ureteral stent insertion, crucial for managing ureteral obstructions, often results in stent-related symptoms (SRSs) adversely affecting patient quality of life. This meta-analysis compares the effectiveness of tamsulosin or mirabegron versus placebo in alleviating these symptoms.

Methods

Following PRISMA guidelines, we systematically reviewed randomized controlled trials (RCTs) comparing mirabegron or tamsulosin to placebo in managing SRSs. Data sources included PubMed, Embase, Web of Science and CENTRAL, up to November 2023. The inclusion criteria focused on studies reporting on Ureteral Stent Symptom Questionnaire (USSQ), International Prostate Symptom Score (IPSS), quality of life (QoL) assessments, analgesic usage and adverse events. Meta-analysis employed a

SUBMITTER: Madarshahian D 

PROVIDER: S-EPMC12425636 | biostudies-literature | 2025 Sep

REPOSITORIES: biostudies-literature